• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.66% Nasdaq Up0.88%

    Sunesis Pharmaceuticals, Inc. (SNSS)

    -NasdaqCM
    0.51 Down 0.01(1.35%) May 2, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 3,061   5,734   7,956  
    Cost of Revenue -   -   -  
    Gross Profit 3,061   5,734   7,956  
    Operating Expenses
    Research Development23,701  27,665  28,891  
    Selling General and Administrative18,662  23,112  10,838  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (39,302) (45,043) (31,773)
    Income from Continuing Operations
    Total Other Income/Expenses Net3,565  3,760  92  
    Earnings Before Interest And Taxes(35,737)(41,283)(31,681)
    Interest Expense939  1,719  2,917  
    Income Before Tax(36,676)(43,002)(34,598)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(36,676)(43,002)(34,598)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (36,676) (43,002) (34,598)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (36,676) (43,002) (34,598)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.